vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $30.1M, roughly 1.6× Dominari Holdings Inc.). STEM, INC. runs the higher net margin — -33.9% vs -438.1%, a 404.2% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs -15.6%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs 36.1%).
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
DOMH vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $47.1M |
| Net Profit | $-131.8M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -8.9% | -17.7% |
| Net Margin | -438.1% | -33.9% |
| Revenue YoY | 220.4% | -15.6% |
| Net Profit YoY | -12426.2% | 68.8% |
| EPS (diluted) | $-6.94 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $47.1M | ||
| Q3 25 | $50.8M | $38.2M | ||
| Q2 25 | $34.1M | $38.4M | ||
| Q1 25 | $8.1M | $32.5M | ||
| Q4 24 | $9.4M | $55.8M | ||
| Q3 24 | $4.0M | $29.3M | ||
| Q2 24 | $6.2M | $34.0M | ||
| Q1 24 | $1.4M | $25.5M |
| Q4 25 | $-131.8M | $-16.0M | ||
| Q3 25 | $125.2M | $-23.8M | ||
| Q2 25 | $16.6M | $202.5M | ||
| Q1 25 | $-32.5M | $-25.0M | ||
| Q4 24 | $1.1M | $-51.1M | ||
| Q3 24 | $-4.2M | $-148.3M | ||
| Q2 24 | $-6.1M | $-582.3M | ||
| Q1 24 | $-5.4M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -8.9% | -17.7% | ||
| Q3 25 | -3.1% | -33.6% | ||
| Q2 25 | -57.0% | -34.8% | ||
| Q1 25 | -394.6% | -65.0% | ||
| Q4 24 | 0.4% | -84.4% | ||
| Q3 24 | -79.1% | -493.2% | ||
| Q2 24 | -44.3% | -1705.5% | ||
| Q1 24 | -205.2% | -267.0% |
| Q4 25 | -438.1% | -33.9% | ||
| Q3 25 | 246.4% | -62.2% | ||
| Q2 25 | 48.7% | 527.8% | ||
| Q1 25 | -400.5% | -76.9% | ||
| Q4 24 | 11.4% | -91.6% | ||
| Q3 24 | -104.2% | -506.3% | ||
| Q2 24 | -99.1% | -1712.6% | ||
| Q1 24 | -398.0% | -283.9% |
| Q4 25 | $-6.94 | $-4.40 | ||
| Q3 25 | $7.27 | $-2.84 | ||
| Q2 25 | $1.12 | $-1.79 | ||
| Q1 25 | $-3.02 | $-0.15 | ||
| Q4 24 | $0.21 | $-15.29 | ||
| Q3 24 | $-0.67 | $-18.24 | ||
| Q2 24 | $-1.01 | $-71.81 | ||
| Q1 24 | $-0.91 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $-249.4M |
| Total Assets | $112.9M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $48.9M | ||
| Q3 25 | $176.2M | $43.1M | ||
| Q2 25 | $28.2M | $40.8M | ||
| Q1 25 | $18.9M | $58.6M | ||
| Q4 24 | $8.2M | $56.3M | ||
| Q3 24 | $7.2M | $75.4M | ||
| Q2 24 | $12.1M | $89.6M | ||
| Q1 24 | $7.1M | $112.8M |
| Q4 25 | $69.4M | $-249.4M | ||
| Q3 25 | $210.2M | $-235.7M | ||
| Q2 25 | $88.6M | $-214.1M | ||
| Q1 25 | $42.4M | $-417.5M | ||
| Q4 24 | $39.9M | $-398.4M | ||
| Q3 24 | $38.3M | $-344.1M | ||
| Q2 24 | $42.4M | $-203.2M | ||
| Q1 24 | $47.7M | $371.6M |
| Q4 25 | $112.9M | $308.9M | ||
| Q3 25 | $223.4M | $362.6M | ||
| Q2 25 | $109.3M | $379.2M | ||
| Q1 25 | $52.3M | $405.1M | ||
| Q4 24 | $47.1M | $437.4M | ||
| Q3 24 | $43.4M | $537.8M | ||
| Q2 24 | $49.1M | $691.5M | ||
| Q1 24 | $52.2M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $8.2M | ||
| Q3 25 | $-4.9M | $11.4M | ||
| Q2 25 | $-353.0K | $-21.3M | ||
| Q1 25 | $1.2M | $8.5M | ||
| Q4 24 | $-16.7M | $-14.7M | ||
| Q3 24 | $-4.7M | $-9.4M | ||
| Q2 24 | $1.4M | $-11.9M | ||
| Q1 24 | $-8.6M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
STEM
Segment breakdown not available.
